GPR40 agonist 4 is a potentfree fatty acid receptor1(FFA1/ GPR40) agonist with apEC₅₀of 7.54.

pEC₅₀: 7.54 (FFA1/GPR40)^[1]

GPR40 agonist 4 tends to have a low risk of activating caspase-3/7^[1].

Single oral administration of GPR40 agonist 4 (compound 20) robustly reduces the plasma glucose excursion and enhances insulin secretion during an oral glucose tolerance test (OGTT) in a dose-dependent manner from 1 to 10 mg/kg when GPR40 agonist 4 is dosed 60 min prior to the oral glucose challenge. The area under the curve of blood glucose (AUC_0-120min) and blood insulin (AUC_0-120min) reveal that the minimum effective dose of GPR40 agonist 4 is 3 mg/kg. The hyperglycemia state is also markedly improved in GPR40 agonist 4 (20 mg/kg) treated group^[1].

416.87

Solid

C₂₁H₁₇ClO₅S

2102196-57-4

Room temperature in continental US; may vary elsewhere.

DMSO : 160 mg/mL(383.81 mM;Need ultrasonic and warming)

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。